checkAd

     260  0 Kommentare Alkermes Commences Arbitration Related to License Agreements with Janssen Pharmaceutica - Seite 3

    NanoCrystal is a registered trademark of Alkermes Pharma Ireland Limited, used by Alkermes, Inc. under license; and INVEGA SUSTENNA, INVEGA TRINZA, and INVEGA HAFYERA are registered trademarks of Johnson & Johnson Corporation. CABENUVA is a registered trademark of ViiV Healthcare UK (No.3) Limited.

    Alkermes Contacts:

    For Investors:

    Sandy Coombs,   +1 781 609 6377

    For Media:

    Katie Joyce,   +1 781 249 8927

     

    Alkermes plc Logo

    Lesen Sie auch

    Logo - https://mma.prnewswire.com/media/616416/Alkermes_plc_Logo.jpg 

    Seite 3 von 3



    PR Newswire (engl.)
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors


    Verfasst von PR Newswire (engl.)
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Alkermes Commences Arbitration Related to License Agreements with Janssen Pharmaceutica - Seite 3 DUBLIN, April 19, 2022 /PRNewswire/ - Alkermes plc (Nasdaq: ALKS) today announced that it commenced binding arbitration proceedings in respect of two license agreements with Janssen Pharmaceutica N.V. ("Janssen"), a subsidiary of Johnson & Johnson. …